type 2 diabetes
Takeda Terminates Development Of Fasiglifam
Takeda has decided to terminate the development activities for fasiglifam, an investigational treatment for type II diabetes, due to concerns about liver safety.
Artificially Sweeteners ‘Neutral’ To The Gut: Study
Artificially sweetened drinks produced no different response in the healthy human gut to a glass of water, according to a study.
Scientists Study ‘Obesity Paradox’ In Diabetics
People who are obese when they’re diagnosed with type II diabetes have much better survival rates than those with a healthy weight at the time of diagnosis, scientists say.
Gastric Banding Rapidly Reverses Diabetes
Researchers have shown that gastric banding, a form of weight loss surgery, brings about rapid reversal of diabetes in some patients.
Thin People Get Diabetes Too, Study
A study has found that blaming fat as the cause of diabetes is misleading and wrongly promotes the idea that the condition is self-induced.
Takeda Receives Marketing Authorization For NESINA In China
The China Food and Drug Administration has issued an Import Drug License for Takeda's type 2 diabetes drug.
